Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10696654
Therapeutic compounds
granted -
US 10695435
Composition comprising a polymeric reagent
granted -
US 10695372
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10695355
Methods for pharmacologic treatment of stroke
granted -
US 10695414
Modulation of replicative fitness by deoptimization of synonymous codons
granted -
US 10695325
Compounds and methods for treating an epileptic disorder
granted -
US 10695429
Pharmaceutical compositions comprising meloxicam
granted -
US 10695304
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
US 10695308
Inhalation formulations of treprostinil
granted -
US 10695279
Peptide having skin-whitening activity and use thereof
granted -
US 10695431
Solid solution compositions and use in cardiovascular disease
granted -
US 10696693
Fused imidazole derivatives as TGF-beta inhibitors
granted -
US 10695293
Method of preventing or treating radiation-induced dermatitis with extracellular vesicles
granted -
US 10696710
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10696713
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 10695352
Combination therapy for treating malignancies
granted -
US 10696651
Heterocyclic compound
granted -
US 10695296
Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient
granted -
US 2020199221
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
granted -
EP 3668502
MAKROCYCLISCHE MCL-1-INHIBITOREN UND VERFAHREN ZUR VERWENDUNG
granted -
US 10688160
Enzymes and methods for cleaving N-glycans from glycoproteins
granted -
US 10688102
Combination treatment for migraine and other pain
granted -
US 10689392
Anti-cancer compounds targeting ral GTPases and methods of using the same
granted -
US 10689347
Substituted heterocyclyl derivatives as CDK inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.